Clinical, serologic and magnetic resonance imaging of 3 cases of inflammatory myopathy with abundant macrophages in the Japanese population

详细信息    查看全文

• 作者：Shintaro Hara (1)
  Tomoko Henmi (2)
  Atsushi Kawakami (2)
  Keita Fujikawa (2)
  Hiroshi Mukae (3)
  Yuji Ishimatsu (1)
  Noriho Sakamoto (1)
  Tomoyuki Kakugawa (1)
  Kenzou Kaji (4)
  Manabu Fujimoto (4)
  Masataka Kuwana (5)
  Toshiaki Tsukada (6)
  Katsuya Satoh (2)
  Masakatsu Motomura (2)
  Mami Tamai (2)
  Hideki Nakamura (2)
  Hiroaki Ida (2)
  Tomayoshi Hayashi (7)
  Tomoki Origuchi (8)
  Katsumi Eguchi (2)
  Shigeru Kohno (1)
  
• 关键词：IMAM ; MAS ; Myositis ; specific autoantibodies ; MRI
• 刊名：Rheumatology International
• 出版年：2013
• 出版时间：April 2013
• 年：2013
• 卷：33
• 期：4
• 页码：1059-1064
• 全文大小：600KB
• 参考文献：1. Gherardi RK, Coquet M, Cherin P, Authier FJ, Laforet P, Belec L, Figarella-Branger D, Mussini JM, Pellissier JF, Fardeau M (1998) Macrophagic myofasciitis: an emerging entity. Groupe d’Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l’Association Francaise contre les Myopathies (AFM). Lancet 352(9125):347-52 CrossRef
  2. Bassez G, Authier F-J, Lechapt-Zalcman E, Delfau-Larue ME, Plonquet A, Coquet M, Illa I, Gherardi RK (2003) Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis. J Neuropathol Exp Neurol 62:464-74
  3. Carrera E, Lobrinus JA, Spertini O, Gherardi RK, Kuntzer T (2006) Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages. Neuromuscul Disord 16:468-71. doi:10.1016/j.nmd.2006.05.008 CrossRef
  4. Brunn A, Hans VJ, Vogelgesang S, Deckert M (2009) Inflammatory myopathy with abundant macrophages and dermatomyositis: two stages of one disorder or two distinct entities? Acta Neuropathol [Epub ahead of print] doi:10.1007/s00401-009-0570-8
  5. Cherin P, Laforet P et al (1999) [Macrophagic myofasciitis: description and etiopathogenic hypotheses. Study and research group on Acquired and Dysimmunity-related Muscular Diseases (GERMMAD) of the French Association against Myopathies (AFM)] (in French). Rev Med Interne 20(6):483-89 CrossRef
  6. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ (2003) Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 27(4):407-25. doi:10.1002/mus.10313 CrossRef
  7. Guis S, Roudier J (2004) Comments about the editorial by Thomas Papo entitled “Macrophagic myofasciitis: focal or systemic?- Joint Bone Spine 71(2):164; author rely -5. doi:10.1016/j.jbspin.2003.10.013
  8. Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17(5):561-67 CrossRef
  9. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344-47 CrossRef
  10. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403-07 CrossRef
  11. Fujikawa K, Kawakami A, Kaji K, Fujimoto M, Kawashiri S, Iwamoto N, Aramaki T, Ichinose K, Tamai M, Kamachi M, Nakamura H, Ida H, Origuchi T, Ishimoto H, Kuwana M, Kohno S, Takehara K, Sato S, Eguchi K (2009) Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol 14:1-. [Epub ahead of print] doi:10.1080/03009740802687455
  12. Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, Ishimatsu Y, Kawakami A, Eguchi K, Kohno S (2009) Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classical dermatomyositis. Chest 136(5):1341-347. doi:10.1378/chest.08-2740 CrossRef
  13. Emmenegger U, Schaer DJ, Larroche C, Neftel KA (2005) Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 135:299-14. doi:2005/21/smw-10976
  14. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818-24
  15. Reimers CD, Schedel H, Fleckenstein JL, Nagele M, Witt TN, Pongratz DE, Vogl TJ, Finkenstaeds M (1994) Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults: muscle imaging in inflammatory myopathies. J Neurol 241(5):306-14 CrossRef
  16. Reimers CD, Finkenstaedt M (1997) Muscle imaging in inflammatory myopathies. Curr Opin Rheumatol 9(6):475-85 CrossRef
  17. Guis S, Mattei JP, Pellissier JF, Nicoli F, Figarella-Branger D, Le Fur Y, Kaplanski G, Pelletier J, Harle JR, Cozzone PJ, Bendahan D (2004) MRI and 31PMR spectroscopy investigations of muscle function disclose no abnormality in macrophagic myofasciitis. J Rheumatol 31(11):2313-314
  18. Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M (2006) Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis. Arthritis Rheum 54:2004-009. doi:10.1002/art.21883 CrossRef
  19. Alegre VA, Winkelmann RK (1989) Histiocytic cytophagic panniculitis. J Am Acad Dermatol 20(2 Pt 1):177-85 CrossRef
  20. Craig AJ, Cualing H, Thomas G, Lamerson C, Smith R (1998) Cytophagic histiocytic panniculitis—a syndrome associated with benign and malignant panniculitis: case comparison and review of the literature. J Am Acad Dermatol 39(5 Pt 1):721-36 CrossRef
  21. Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14(5):548-52 CrossRef
  22. Ma X (2001) TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 3:121-29 CrossRef
  23. Shamji MF, Chen J, Friedman AH, Richardson WJ, Chilkoti A, Setton LA (2008) Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. J Control Release 129(3):179-86. doi:10.1016/j.jconrel.2008.04.021 CrossRef
  24. Izumi Y, Ida H, Huang M, Iwanaga N, Tanaka F, Aratake K, Arima K, Tamai M, Kamachi M, Nakamura H, Origuchi T, Kawakami A, Anderson P, Eguchi K (2006) Characterization of peripheral natural killer cells in primary Sjogren’s syndrome: impaired NK cell activity and low NK cell number. J Lab Clin Med 147(5):242-49. doi:10.1016/j.lab.2006.01.001 CrossRef
  25. Yajima N, Wakabayashi K, Odai T, Isozaki T, Matsunawa M, Miwa Y, Negishi M, Ide H, Kasama T (2008) Clinical features of hemophagocytic syndrome in patients with dermatomyositis. J Rheumatol 35(9):1838-841
  
• 作者单位：Shintaro Hara (1)
  Tomoko Henmi (2)
  Atsushi Kawakami (2)
  Keita Fujikawa (2)
  Hiroshi Mukae (3)
  Yuji Ishimatsu (1)
  Noriho Sakamoto (1)
  Tomoyuki Kakugawa (1)
  Kenzou Kaji (4)
  Manabu Fujimoto (4)
  Masataka Kuwana (5)
  Toshiaki Tsukada (6)
  Katsuya Satoh (2)
  Masakatsu Motomura (2)
  Mami Tamai (2)
  Hideki Nakamura (2)
  Hiroaki Ida (2)
  Tomayoshi Hayashi (7)
  Tomoki Origuchi (8)
  Katsumi Eguchi (2)
  Shigeru Kohno (1)
  
  1. Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
  2. Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
  3. Department of Respiratory Medicine, University of Occupational and Environmental Health, Fukuoka, Japan
  4. Department of Dermatology, Kanazawa University Graduate School of Medical Science, Ishikawa, Japan
  5. Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
  6. Department of Internal Medicine, Isahaya Health Insurance General Hospital, Nagasaki, Japan
  7. Department of Pathology, Nagasaki University Hospital, Nagasaki, Japan
  8. Nagasaki University School of Health Sciences, Nagasaki University, Nagasaki, Japan
  

文摘

We report the first 3 cases of inflammatory myopathy with abundant macrophages (IMAM) to be found in an Asian country. Diagnosis of IMAM was based on the infiltration of CD68+?macrophages into biopsied specimens, particularly the fascia. Proximal skeletal muscle symptoms and signs, elevation of creatine kinase, and myogenic changes in electromyography were found in all of the cases, and magnetic resonance imaging clearly revealed thickening of the fascia. Since dermatomyositis (DM)-specific skin alterations were not found, none of the patients in this study fulfilled Bohan and Peter’s criteria for DM; however, anti-PL-7 antibody was detected in case number 1. In addition, CD20+?B-cell infiltration into the fascia was also detected in all of the cases, indicating further transition to DM. Severe illness, namely macrophage activation syndrome and acute respiratory distress syndrome, occurred in case 1 but was resolved with intensive combination therapy. The other 2 cases also required glucocorticoids to achieve remission.